Halo Therapeutics: CEO Torley Helen Buys, Sells Shares Amid Market Volatility

Halozyme Therapeutics, Inc. (HALO) has announced that Torley Helen, the company's President and CEO, has made several transactions involving the purchase and sale of shares. On February 3, 2026, Ms. Helen purchased 20,000 shares at a price of $12.07 per share and sold 7,790 shares at $76.73 per share. On February 4, 2026, she purchased 20,000 shares at $12.07 per share and sold 10,100 shares at $77.54 per share. On February 5, 2026, Ms. Helen sold 5,376 shares at $78.38 per share, 4,624 shares at $78.94 per share, and 9,900 shares at $76.94 per share.